Enhancement of cisplatin-based TACE by a hemoglobin-based oxygen carrier in an orthotopic rat HCC model.
about
A novel oxygen carrier "YQ23" suppresses the liver tumor metastasis by decreasing circulating endothelial progenitor cells and regulatory T cells.Oxygen carrier YQ23 can enhance the chemotherapeutic drug responses of chemoresistant esophageal tumor xenografts.Endoplasmic reticulum stress signaling and chemotherapy resistance in solid cancers.A hemoglobin-based oxygen carrier sensitized Cisplatin based chemotherapy in hepatocellular carcinoma.
P2860
Enhancement of cisplatin-based TACE by a hemoglobin-based oxygen carrier in an orthotopic rat HCC model.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Enhancement of cisplatin-based ...... n an orthotopic rat HCC model.
@en
Enhancement of cisplatin-based ...... n an orthotopic rat HCC model.
@nl
type
label
Enhancement of cisplatin-based ...... n an orthotopic rat HCC model.
@en
Enhancement of cisplatin-based ...... n an orthotopic rat HCC model.
@nl
prefLabel
Enhancement of cisplatin-based ...... n an orthotopic rat HCC model.
@en
Enhancement of cisplatin-based ...... n an orthotopic rat HCC model.
@nl
P2093
P2860
P1476
Enhancement of cisplatin-based ...... n an orthotopic rat HCC model.
@en
P2093
Chang-Chun Ling
Chung-Mau Lo
Judy Wai-Ping Yam
Kevin Tak-Pan Ng
Qiao Cheng
Xiao-Bing Liu
Xin-Yuan Guan
P2860
P304
P356
10.3109/21691401.2013.808647
P577
2013-06-25T00:00:00Z